Delivery Order SPE2DR25D2100-SPE2DR26FA1MJ
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,361.20 by the Defense Logistics Agency (DLA) on January 29, 2026, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by January 30, 2026. Performance will occur at the company's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a Delivery Order award from the Defense Logistics Agency on January 21, 2026, for NovoLog 100 Unit/mL FlexPen 3mL insulin pens valued at $8,349.53 with a completion date of January 22, 2026. This non-set-aside, firm fixed-price contract was awarded competitively and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with a ceiling value of $1,354.88 and an ultimate completion date of July 31, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,976.49 by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. The contract operates under firm fixed-price terms with an ultimate completion date of September 29, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is executed as a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $3,712.40 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of December 1, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for NovoLog 100 Unit/mL FlexPen 3mL insulin pens with a ceiling value of $5,938.50. This firm fixed price delivery order, awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive award under an existing contract vehicle. The award supports the Defense Logistics...
- On January 22, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,448.16 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This firm fixed-price delivery order, which is set to be completed by January 23, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant IDC...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $1,970.02 for NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This firm fixed-price contract, awarded on November 25, 2025, with an ultimate completion date of November 26, 2025, represents a competitive award with no set-aside designation. The delivery order is issued under AmerisourceBergen's broader Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 30, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This competitively awarded, firm fixed-price contract carries a ceiling value of $5,135.50 with an ultimate completion date of December 31, 2025. The delivery order will be performed at the contractor's corporate office location in...
- AmerisourceBergen Drug Corp was awarded a $2,361.39 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on November 14, 2025, for the supply of NovoLog Penfill 100 Unit/ML 3ML insulin pens. This non-set-aside award is scheduled for completion by November 17, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier to the federal...